A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

NCT00002122 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycoses
Mycobacterium Avium-Intracellulare Infection
HIV Infections

Interventions

DRUG: Azithromycin
DRUG: Rifabutin
DRUG: Fluconazole

Sponsor

Pfizer